BMJ Open (Apr 2022)
Comparative clinical studies of primary chemoradiotherapy versus S-1 and nedaplatin chemotherapy against stage IVb oesophageal squamous cell carcinoma: a multicentre open-label randomised controlled trial
- Xin Wang,
- Bo Song,
- Yang Liu,
- Yun Liu,
- Liping Wu,
- Xiaohong Wang,
- Junqi Liu,
- Anping Zheng,
- Narasimha M Beeraka,
- Kuo Chen,
- Zhang Song,
- Jianchao Luo,
- Yanhui Cui,
- Zhenhe Jia,
- Xiangyu Song,
- Hongqi Wang,
- Xuefeng Qi,
- Jinshan Ren,
- Jixing Cai,
- Xainying Fang,
- Mikhail Y Sinelnikov,
- Vladimir N Nikolenko,
- M V Greeshma,
- Ruitai Fan
Affiliations
- Xin Wang
- Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China
- Bo Song
- College of Physical Education and Sports, Beijing Normal University, Beijing, China
- Yang Liu
- Institute of Health Science, China Medical University, Shenyang, Liaoning, China
- Yun Liu
- Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China
- Liping Wu
- 1 Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
- Xiaohong Wang
- 1 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
- Junqi Liu
- Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China
- Anping Zheng
- Department of Radiation Oncology, Anyang Cancer Hospital, Anyang, China
- Narasimha M Beeraka
- Cancer Center, Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Kuo Chen
- Cancer Center, Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Zhang Song
- Cancer Center, Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Jianchao Luo
- Department of Oncology, The Henan Provincial People`s Hospital, Zhengzhou, China
- Yanhui Cui
- Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China
- Zhenhe Jia
- Department of Oncology, The Xixia County People`s Hospital, xixia, China
- Xiangyu Song
- Department of Radiation Oncology, The Linzhou People`s Hospital, Linzhou, China
- Hongqi Wang
- Department of Radiation Oncology, General Hospital of Pingmei Shenma Medical Group Pingdingshan 467000, Pingmei, China
- Xuefeng Qi
- Department of Radiation Oncology, The Linying County People`s Hospital, Linying, China
- Jinshan Ren
- Department of Radiation Oncology, The First Affiliated Hospital of Nanyang Medical College, Nanyang, China
- Jixing Cai
- Department of Radiation oncology, the Linzhou Cancer Hospital, 456550, P.R, Linzhou, People`s Republic of China
- Xainying Fang
- Department of Oncology, The Xinyang Central Hospital, Xinyang, China
- Mikhail Y Sinelnikov
- Department of Human Anatomy, Sechenov University, Moskva, Moskva, Russian Federation
- Vladimir N Nikolenko
- Department of Human Anatomy, Sechenov University, Moskva, Moskva, Russian Federation
- M V Greeshma
- Center of Excellence in Molecular Biology and Regenerative Medicine (CEMR), Department of Biochemistry, JSS Academy of Higher Education and Research (JSS AHER), JSS Medical College, Mysuru, Karnataka, India
- Ruitai Fan
- Cancer Center, Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- DOI
- https://doi.org/10.1136/bmjopen-2021-055273
- Journal volume & issue
-
Vol. 12,
no. 4
Abstract
No abstracts available.
